Active ingredient
Ustekinumab
51 finished FDA listings contain Ustekinumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-SRLF
- Dosage forms
- Injection, Injection, Solution, Solution
- Routes
- Intravenous, Subcutaneous
- Manufacturers / labelers
- 12
- Strengths listed
- 130 mg/26ml · 45 mg/.5ml · 90 mg/ml
- Brand names in FDA listings
- Imuldosa, Otulfi, Pyzchiva, Selarsdi, Starjemza, Stelara, Steqeyma, Wezlana, Yesintek
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 847083
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 125261 | CENTOCOR ORTHO BIOTECH INC | 2009-09-25 | 4 |
| BLA 761044 | JANSSEN BIOTECH | 2016-09-23 | 2 |
| BLA 761331 | AMGEN INC | 2023-10-31 | 1 |
| BLA 761285 | AMGEN INC | 2023-10-31 | 6 |
| BLA 761343 | ALVOTECH USA INC | 2024-04-16 | 8 |
| BLA 761373 | SAMSUNG BIOEPIS CO LTD | 2024-06-28 | 7 |
| BLA 761425 | SAMSUNG BIOEPIS CO LTD | 2024-06-28 | 2 |
| BLA 761379 | FRESENIUS KABI USA | 2024-09-27 | 6 |
| BLA 761364 | ACCORD BIOPHARMA INC. | 2024-10-10 | 3 |
| BLA 761406 | BIOCON BIOLOGICS INC | 2024-11-29 | 4 |
| BLA 761338 | CELLTRION, INC. | 2024-12-17 | 4 |
| BLA 761419 | BIO-THERA SOLUTIONS LTD | 2025-05-22 | 4 |
Official labeling on DailyMed
- STELARA (USTEKINUMAB) INJECTION, SOLUTION STELARA (USTEKINUMAB) SOLUTION [JANSSEN BIOTECH, INC.] · version 49 · 2026-09-10
- USTEKINUMAB INJECTION, SOLUTION USTEKINUMAB SOLUTION [JANSSEN BIOTECH, INC.] · version 9 · 2026-09-10
- USTEKINUMAB-AEKN INJECTION, SOLUTION [TEVA PHARMACEUTICALS USA, INC.] · version 12 · 2026-08-03
- USTEKINUMAB-AEKN INJECTION, SOLUTION [TEVA PHARMACEUTICALS USA, INC.] · version 7 · 2026-08-03
- PYZCHIVA (USTEKINUMAB-TTWE) INJECTION, SOLUTION [CORDAVIS LIMITED] · version 7 · 2026-07-21
- PYZCHIVA (USTEKINUMAB-TTWE) INJECTION, SOLUTION [SANDOZ INC] · version 17 · 2026-07-15
- SELARSDI (USTEKINUMAB-AEKN) INJECTION, SOLUTION [TEVA PHARMACEUTICALS USA, INC.] · version 16 · 2026-06-26
- IMULDOSA (USTEKINUMAB-SRLF) INJECTION [ACCORD BIOPHARMA INC.] · version 10 · 2026-06-18
- WEZLANA (USTEKINUMAB-AUUB) INJECTION, SOLUTION [NUVAILA LIMITED] · version 9 · 2026-06-09
- STEQEYMA (USTEKINUMAB-STBA) INJECTION, SOLUTION [CELLTRION USA, INC.] · version 12 · 2026-04-14
- OTULFI (USTEKINUMAB-AAUZ) INJECTION, SOLUTION OTULFI (USTEKINUMAB-AAUZ) SOLUTION [FRESENIUS KABI USA, LLC] · version 4 · 2026-03-23
- USTEKINUMAB-AAUZ INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] · version 4 · 2026-03-18
Showing the 12 most recent of 15 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.